Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01502319 · ClinicalTrials.gov registry record

Military Suicide Research Consortium

A clinical trial, sponsored by VA Eastern Colorado Health Care System.

Completed
Registry status
5,400
Enrollment target

NCT01502319: Completed study, sponsored by VA Eastern Colorado Health Care System.

NCT01502319 is a clinical trial that has completed, run by VA Eastern Colorado Health Care System. The registered enrollment target is 5,400 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01502319 has completed, sponsored by VA Eastern Colorado Health Care System.

COMPLETED
Registry status
5,400 participants
Enrollment target

Study Summary

The Consortium's overall mission can be summarized as follows; each function is developed with the goal of clear military relevance: 1. Produce new scientific knowledge about suicidal behavior in the military that improves mental health outcomes for the investigators men and women in uniform. 2. Use high quality research methods and analyses to address problems in policy and practice that have a direct impact on suicide-related and other mental health outcomes for military personnel. 3. Disseminate Consortium knowledge, information, and findings through a variety of methods appropriate for decision makers, practitioners, and others who are accountable for ensuring the mental health of military personnel. This includes the rapid response function so that queries from decision makers and others to the Consortium are answered with speed and efficiency. Technical assistance and support for decision makers and others is an integral aspect of this Consortium function. This aspect of the Consortium will warehouse knowledge about suicidal behavior in general (e.g., from civilian and international sources as well as from military sources), so that military issues can be informed in a comprehensive manner. 4. Train future leaders in military suicide research through experience within a multi-disciplinary setting for Ph.D. students and postdoctoral scholars interested in research questions on military suicide of both a basic and applied nature.

Primary Outcome

Specific outcomes related to suicide will vary as a function of the individual studies conducted within the consortium

Interventions

  • BEHAVIORAL Cognitive therapy

Trial Details

FieldValue
Enrollment Target 5,400 participants
Start Date 2010-09
Est. Completion 2017-09

What the finished NCT01502319 record still lists

NCT01502319 is an observational study that tracks outcomes without assigning an intervention. Its 5,400 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 1 intervention - of which Cognitive therapy is the first listed.

NCT01502319 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01502319 about?

NCT01502319 is a clinical study titled "Military Suicide Research Consortium". The Consortium's overall mission can be summarized as follows; each function is developed with the goal of clear military relevance: 1. Produce new scientific knowledge about suicidal behavior in the military that improves mental health outcomes for the investigators men and women in uniform. 2. Us...

What is the current status of trial NCT01502319?

This trial is currently completed. The enrollment target is 5,400 participants. The study started on 2010-09. Estimated completion is 2017-09.

What interventions are being tested in trial NCT01502319?

The interventions under investigation include: Cognitive therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT01502319?

This trial is sponsored by VA Eastern Colorado Health Care System, which has 42 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05722769 · 5,408 participants · NA

    CSTOP Now! Child Sex Trafficking Stops With You

  • NCT05836987 · 5,350 participants · Phase 3

    The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

  • NCT05373771 · 5,328 participants · NA

    Sickle Cell Improvement: Enhancing Care in the Emergency Department

  • NCT04295486 · 5,478 participants · Phase 2

    Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01502319, the US trial registry maintained by the National Library of Medicine. NCT01502319 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.